John Overdeck’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Buy
29,239
+12,880
+79% +$1.3M ﹤0.01% 2651
2026
Q1
$1.45M Buy
16,359
+4,124
+34% +$355K ﹤0.01% 3000
2025
Q4
$960K Buy
12,235
+2,612
+27% +$199K ﹤0.01% 2943
2025
Q3
$645K Buy
+9,623
New +$693K ﹤0.01% 2861
2023
Q3
Sell
-2,146
Closed -$276K 3111
2023
Q2
$276K Buy
+2,146
New +$327K ﹤0.01% 2539
2022
Q4
Sell
-1,898
Closed -$267K 2971
2022
Q3
$267K Buy
+1,898
New +$346K ﹤0.01% 2003
2021
Q4
Sell
-800
Closed -$242K 4623
2021
Q3
$242K Sell
800
-10,747
-93% -$3.05M ﹤0.01% 3830
2021
Q2
$3.13M Sell
11,547
-10,497
-48% -$2.66M 0.01% 1518
2021
Q1
$5.37M Buy
22,044
+20,244
+1,125% +$5.57M 0.01% 997
2020
Q4
$516K Sell
1,800
-1,700
-49% -$468K ﹤0.01% 2492
2020
Q3
$892K Buy
+3,500
New +$832K ﹤0.01% 1838
2018
Q4
Sell
-14,507
Closed -$2.69M 3325
2018
Q3
$2.69M Sell
14,507
-192
-1% -$38.6K 0.01% 1278
2018
Q2
$3.1M Buy
+14,699
New +$2.57M 0.01% 1325
2017
Q2
Sell
-5,241
Closed -$643K 3160
2017
Q1
$643K Hold
5,241
﹤0.01% 2183
2016
Q4
$643K Hold
5,241
﹤0.01% 2335
2016
Q3
$599K Sell
5,241
-263
-5% -$30K ﹤0.01% 2332
2016
Q2
$677K Buy
5,504
+1,773
+48% +$191K ﹤0.01% 2039
2016
Q1
$359K Sell
3,731
-823
-18% -$74.2K ﹤0.01% 2276
2015
Q4
$453K Sell
4,554
-600
-12% -$64.2K ﹤0.01% 2024
2015
Q3
$574K Buy
5,154
+300
+6% +$31.7K ﹤0.01% 1479
2015
Q2
$432K Sell
4,854
-400
-8% -$33.8K ﹤0.01% 2210
2015
Q1
$379K Sell
5,254
-1,052
-17% -$78.3K ﹤0.01% 2134
2014
Q4
$488K Buy
+6,306
New +$462K ﹤0.01% 1735
2014
Q3
Sell
-3,817
Closed -$320K 1932
2014
Q2
$320K Buy
3,817
+428
+13% +$35.4K ﹤0.01% 1804
2014
Q1
$306K Buy
3,389
+689
+26% +$58.5K ﹤0.01% 1669
2013
Q4
$212K Sell
2,700
-900
-25% -$65.6K ﹤0.01% 1992
2013
Q3
$244K Sell
3,600
-5,298
-60% -$339K ﹤0.01% 1569
2013
Q2
$482K Buy
+8,898
New +$462K ﹤0.01% 1428

Other funds holding MLAB

John Overdeck's MLAB Position: Q2 2026 in Review

John Overdeck increased its Mesa Laboratories (MLAB) stake by 79% in Q2 2026, buying an estimated $1.3M and bringing the position to 29,239 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

John Overdeck first reported a position in MLAB in Q2 2013 and has held it in 28 quarters since. The position peaked at $5.37M in Q1 2021. 157 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • John Overdeck held 29,239 shares of Mesa Laboratories worth $2.91M as of Q2 2026.
  • John Overdeck bought 12,880 Mesa Laboratories shares in Q2 2026, an estimated $1.3M.
  • Mesa Laboratories made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2651 holding.
  • John Overdeck first reported a position in Mesa Laboratories in Q2 2013 and has held it in 28 quarters since.
  • John Overdeck's Mesa Laboratories position peaked at $5.37M in Q1 2021.
  • 157 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.